Corrigendum to ‘The peptidic GHS-R antagonist [d-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity’ [Molecular and Cellular Endocrinology 343 (1–2) (2011) 55–62]